Osteoporosis After 60
The article explains who should get a bone density test in Canada, how osteoporosis treatments including bisphosphonates and newer injectable drugs compare in 2026, what provincial drug plans cover, and how to reduce fracture risk after 60. To choose a suitable option, compare the scope, current price structure, conditions, timing and possible limitations.
This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.
Osteoporosis symptoms
Osteoporosis often develops quietly, which is why many people do not notice it until a fracture happens. Common osteoporosis symptoms can include loss of height over time, a more stooped posture, back pain linked to spinal compression fractures, and bones that break more easily than expected. Hip, wrist, and spine fractures are especially important warning signs in older adults, because they may point to weakening bone structure that has been building for years.
Bone density test
A bone density test, often called a DXA or DEXA scan, is the standard way to measure bone strength and estimate fracture risk. The scan is painless, quick, and commonly focuses on the hip and spine. In Canada, doctors may recommend testing when age, family history, a previous fracture, long-term steroid use, menopause, or other health conditions raise concern. Results are usually reported as T-scores, which help guide monitoring and treatment decisions.
Osteoporosis treatment options
Osteoporosis treatment usually combines medication with practical lifestyle measures. Weight-bearing activity, balance training, resistance exercise, adequate calcium intake, and vitamin D support are often part of the plan. Fall prevention also matters, especially in homes with stairs, loose rugs, or poor lighting. Treatment goals are generally to slow bone loss, reduce fracture risk, preserve mobility, and support independence rather than to produce quick or dramatic short-term changes.
Osteoporosis medication choices
Osteoporosis medication is not one-size-fits-all. Some people are prescribed bisphosphonates such as alendronate or risedronate, which are often used early because they are widely available and may be taken weekly or monthly. Others may receive denosumab, teriparatide, romosozumab, or zoledronic acid when fracture risk is higher or when oral treatment is unsuitable. Doctors usually consider kidney function, previous fractures, dosing convenience, side effects, and how long treatment should continue.
Osteoporosis injection cost in Canada
Real-world pricing can vary widely across Canada because public coverage, private insurance, dispensing fees, infusion fees, and provincial formularies are not the same everywhere. Injectable or infusion-based therapies are often more expensive than standard oral tablets, but some patients pay far less out of pocket when coverage applies. The figures below are broad cost estimates based on typical Canadian benchmarks for commonly used products and should be treated as planning ranges rather than fixed prices.
| Product/Service | Provider | Cost Estimation |
|---|---|---|
| Prolia (denosumab) injection | Amgen Canada | Often about CAD 300-450 per injection before pharmacy or administration fees |
| Aclasta (zoledronic acid) infusion | Novartis Canada | Often about CAD 500-700 per yearly infusion, with possible added clinic fees |
| Forteo (teriparatide) injection pen | Eli Lilly Canada | Often about CAD 900-1,200 per month depending on pharmacy pricing |
| Evenity (romosozumab) monthly injections | Amgen Canada | Often about CAD 400-700 per monthly treatment set before dispensing fees |
Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.
Knowing how symptoms, testing, medication, and costs fit together can make osteoporosis easier to understand in later life. The condition is common, but it is not managed by age alone; fracture history, bone density results, overall health, and day-to-day function all shape care decisions. A clear diagnosis and an individualized treatment plan usually matter more than any single test result or medication category.